| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.27B | 61.57B | 54.49B | 48.38B | 45.32B | 41.04B |
| Gross Profit | 15.94B | 15.18B | 13.68B | 12.24B | 11.46B | 9.79B |
| EBITDA | 3.46B | 2.96B | 2.61B | 2.58B | 2.85B | 2.83B |
| Net Income | 1.43B | 992.00M | 1.21B | 1.18B | 1.48B | 852.00M |
Balance Sheet | ||||||
| Total Assets | 34.73B | 36.41B | 33.69B | 30.90B | 27.68B | 24.80B |
| Cash, Cash Equivalents and Short-Term Investments | 9.06B | 8.30B | 7.47B | 7.01B | 7.29B | 6.63B |
| Total Debt | 2.48B | 2.87B | 2.96B | 2.81B | 2.12B | 2.53B |
| Total Liabilities | 20.41B | 22.06B | 20.47B | 18.40B | 16.28B | 14.92B |
| Stockholders Equity | 12.25B | 12.24B | 11.41B | 10.54B | 9.44B | 7.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.29B | 1.42B | 1.37B | 1.76B | 1.66B |
| Operating Cash Flow | 0.00 | 1.42B | 1.52B | 1.59B | 2.23B | 1.92B |
| Investing Cash Flow | 0.00 | -218.00M | -268.00M | -2.05B | -725.00M | -112.00M |
| Financing Cash Flow | 0.00 | -475.00M | -813.00M | 56.00M | -871.00M | -1.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥18.37B | 13.52 | ― | 3.53% | 5.03% | -9.55% | |
75 Outperform | ¥9.54B | 12.83 | ― | 3.85% | 1.75% | 24.87% | |
66 Neutral | ¥21.85B | 23.11 | ― | ― | 30.15% | 31.28% | |
63 Neutral | ¥13.56B | 4.95 | ― | 1.47% | 10.12% | 21.04% | |
62 Neutral | ¥3.22B | 5.37 | ― | ― | -3.76% | -67.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
45 Neutral | ¥3.38B | -275.17 | ― | ― | 4.84% | -54.50% |